![Teva to Host Conference Call to Discuss Third Quarter 2022 Financial Results at 8 a.m. ET on November 3, 2022 | Business Wire Teva to Host Conference Call to Discuss Third Quarter 2022 Financial Results at 8 a.m. ET on November 3, 2022 | Business Wire](https://mms.businesswire.com/media/20221006005712/en/739014/23/teva_RGB_JPEG.jpg)
Teva to Host Conference Call to Discuss Third Quarter 2022 Financial Results at 8 a.m. ET on November 3, 2022 | Business Wire
![TEVA PHARMA @ ANZAN Introducing Teva Pharma to the ANZAN conference in Auckland requires a lot of 'presence… | Experiential marketing, Experiential, Branding design TEVA PHARMA @ ANZAN Introducing Teva Pharma to the ANZAN conference in Auckland requires a lot of 'presence… | Experiential marketing, Experiential, Branding design](https://i.pinimg.com/736x/fa/d7/e9/fad7e9d456fb75d4dc1a2540bcb9af95--auckland-exhibition.jpg)
TEVA PHARMA @ ANZAN Introducing Teva Pharma to the ANZAN conference in Auckland requires a lot of 'presence… | Experiential marketing, Experiential, Branding design
Teva to Host Conference Call to Discuss Third Quarter 2022 Financial Results at 8 a.m. ET on November 3, 2022
Teva Pharmaceutical Industries Ltd. - Erez Vigodman, Teva CEO, offered a look at Teva's big picture today at the JP Morgan Healthcare conference: “In 2014 we solidified the foundation. 2015 was transformative
![Shlomo Yanai, Teva's president and chief executive, speaks to the media during a news conference in Tel Aviv July 27, 2010. Teva Pharmaceutical Industries, the world's largest generic drugmaker, reported higher quarterly Shlomo Yanai, Teva's president and chief executive, speaks to the media during a news conference in Tel Aviv July 27, 2010. Teva Pharmaceutical Industries, the world's largest generic drugmaker, reported higher quarterly](https://c8.alamy.com/comp/2D1NC3K/shlomo-yanai-tevas-president-and-chief-executive-speaks-to-the-media-during-a-news-conference-in-tel-aviv-july-27-2010-teva-pharmaceutical-industries-the-worlds-largest-generic-drugmaker-reported-higher-quarterly-net-profit-on-tuesday-boosted-by-sales-of-generic-medicines-and-its-own-branded-multiple-sclerosis-treatment-copaxone-reutersnir-elias-israel-tags-business-headshot-2D1NC3K.jpg)
Shlomo Yanai, Teva's president and chief executive, speaks to the media during a news conference in Tel Aviv July 27, 2010. Teva Pharmaceutical Industries, the world's largest generic drugmaker, reported higher quarterly
![Teva to Settle US Opioid Lawsuits for $4.35 Billion | The Jewish Press - JewishPress.com | David Israel | 28 Tammuz 5782 – July 27, 2022 | JewishPress.com Teva to Settle US Opioid Lawsuits for $4.35 Billion | The Jewish Press - JewishPress.com | David Israel | 28 Tammuz 5782 – July 27, 2022 | JewishPress.com](https://www.jewishpress.com/wp-content/uploads/2022/07/Teva-Pharmaceutical-Industries-CEO-Kare-Schultz-speaks-at-a-press-conference-at-the-Tel-Aviv-Stock-Exchange-February-19-2020..jpg)
Teva to Settle US Opioid Lawsuits for $4.35 Billion | The Jewish Press - JewishPress.com | David Israel | 28 Tammuz 5782 – July 27, 2022 | JewishPress.com
![Teva Pharmaceutical CEO Shlomo Yanai delivers a press conference in Cologne, Germany, 18 March 2010. German generics producer Ratiopharm is sold to world's leading generic producer Teva Pharmaceutical at 3.625 billion euro. Teva Pharmaceutical CEO Shlomo Yanai delivers a press conference in Cologne, Germany, 18 March 2010. German generics producer Ratiopharm is sold to world's leading generic producer Teva Pharmaceutical at 3.625 billion euro.](https://c8.alamy.com/comp/D56P1T/teva-pharmaceutical-ceo-shlomo-yanai-delivers-a-press-conference-in-D56P1T.jpg)